NM_000435.3:c.4556T>C

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5

The NM_000435.3(NOTCH3):​c.4556T>C​(p.Leu1519Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NOTCH3
NM_000435.3 missense

Scores

8
10
1

Clinical Significance

Pathogenic no assertion criteria provided P:1O:1

Conservation

PhyloP100: 9.11

Publications

17 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.987
PP5
Variant 19-15174248-A-G is Pathogenic according to our data. Variant chr19-15174248-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 55850.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.4556T>C p.Leu1519Pro missense_variant Exon 25 of 33 ENST00000263388.7 NP_000426.2 Q9UM47
NOTCH3XM_005259924.5 linkc.4400T>C p.Leu1467Pro missense_variant Exon 24 of 32 XP_005259981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.4556T>C p.Leu1519Pro missense_variant Exon 25 of 33 1 NM_000435.3 ENSP00000263388.1 Q9UM47

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1435718
Hom.:
0
Cov.:
37
AF XY:
0.00
AC XY:
0
AN XY:
713186
African (AFR)
AF:
0.00
AC:
0
AN:
32926
American (AMR)
AF:
0.00
AC:
0
AN:
40998
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25730
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38360
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84262
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46802
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5284
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1101968
Other (OTH)
AF:
0.00
AC:
0
AN:
59388
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Myofibromatosis, infantile, 2 Pathogenic:1
Jun 06, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Myofibromatosis, infantile, 1 Other:1
-
Center for Applied Genomics, Children's Hospital of Philadelphia
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Uncertain
0.080
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.74
D
Eigen
Pathogenic
0.73
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D
M_CAP
Pathogenic
0.85
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.74
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
9.1
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-4.3
D
REVEL
Pathogenic
0.81
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.98
D
Vest4
0.86
MutPred
0.79
Gain of glycosylation at L1519 (P = 0.0169);
MVP
0.97
MPC
3.4
ClinPred
0.99
D
GERP RS
4.8
Varity_R
0.97
gMVP
0.95
Mutation Taster
=11/89
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367543285; hg19: chr19-15285059; COSMIC: COSV54644378; COSMIC: COSV54644378; API